On Friday, the U.S. Supreme Court struck down President Donald Trump’s tariffs, citing that he exceeded his authority by invoking an emergency-powers law.
(BPT) - As spring draws near, allergy season follows close behind. While blooming flowers and budding trees may be welcome, they can also bring allergens that trigger sneezing, congestion and itchy, watery eyes for millions. Allergies are nothing to sneeze at: they currently affect approximately 30% of adults and 40% of children in the U.S., making them an ongoing struggle for many.
Hyperscale Data’s plan to stack up silver alongside a 600 BTC treasury worth $41 million turns GPUS stock into a leveraged way to bet on a silver run toward $150.
Dan Loeb’s new stakes in Chipotle, Spotify, and Alibaba are a concentrated bet that markets have overshot on fear in three still‑profitable growth franchises, each with clear multi‑year earnings drivers.
Although MSCI has underperformed relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Gilead Sciences is buying Arcellx for $7.8 billion because it sees potential for more than $6 billion in sales for anito-cel by 2029. GILD stock slipped as ACLX soared.
